Baker Tilly Wealth Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,113
| Closed | -$418K | – | 387 |
|
|
2024
Q1 | $418K | Sell |
2,113
-37
| -2% | -$7.33K | 0.08% | 290 |
|
|
2023
Q4 | $370K | Buy |
2,150
+190
| +10% | +$32.7K | 0.06% | 353 |
|
|
2023
Q3 | $290K | Sell |
1,960
-98
| -5% | -$14.5K | 0.05% | 377 |
|
|
2023
Q2 | $450K | Buy |
2,058
+23
| +1% | +$5.03K | 0.05% | 364 |
|
|
2023
Q1 | $446K | Buy |
2,035
+3
| +0.1% | +$657 | 0.05% | 363 |
|
|
2022
Q4 | $423K | Sell |
2,032
-85
| -4% | -$17.7K | 0.05% | 362 |
|
|
2022
Q3 | $462K | Sell |
2,117
-33
| -2% | -$7.2K | 0.06% | 308 |
|
|
2022
Q2 | $451K | Sell |
2,150
-84
| -4% | -$17.6K | 0.06% | 334 |
|
|
2022
Q1 | $542K | Sell |
2,234
-234
| -9% | -$56.8K | 0.06% | 327 |
|
|
2021
Q4 | $643K | Buy |
2,468
+488
| +25% | +$127K | 0.07% | 302 |
|
|
2021
Q3 | $522K | Sell |
1,980
-60
| -3% | -$15.8K | 0.07% | 304 |
|
|
2021
Q2 | $503K | Buy |
2,040
+326
| +19% | +$80.4K | 0.08% | 275 |
|
|
2021
Q1 | $333K | Buy |
1,714
+374
| +28% | +$72.7K | 0.07% | 335 |
|
|
2020
Q4 | $285K | Buy |
+1,340
| New | +$285K | 0.09% | 249 |
|